Monday, March 03, 2025 | 10:40 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Serum Institute puts India trials of AstraZeneca's Covid-19 vaccine on hold

Serum Institute of India has put trials of AstraZeneca's Covid-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said

Coronavirus, vaccine, covid, drugs, Sepsivac, clinical trials

Reuters MUMBAI

MUMBAI (Reuters) - Serum Institute of India has put trials of AstraZeneca's COVID-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said on Thursday.

"We are reviewing the situation and pausing India trials," Serum said in a brief statement.

AstraZeneca said on Tuesday it had paused trials of its experimental coronavirus vaccine because of an unexplained illness in a study participant, but its partner Serum had at the time said its trials in India were still ongoing.

 

(Reporting by Euan Rocha in Mumbai; Additional reporting by Sachin Ravikumar in Bengaluru; Editing by Shounak Dasgupta)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 10 2020 | 3:45 PM IST

Explore News